Form 4 for ENVB Enveric Biosciences, Inc.
Accepted 2023-03-14 00:00:00 ET · period of report 2023-03-13 · accession 0001493152-23-007662 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-14 | 2023-03-13 | ENVB | Coveney Kevin Michael | CFO | A - Grant | $0.00 | +26.5K | 26.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-13 | A | A | 26,500 | $0.00 | 26,500 | D | — | — | (F2) The RSUs shall vest over 4 years in equal annual installments, with the first tranche to vest on March 13, 2024. (F1) Represents restricted stock units (the "RSUs") granted to the reporting person. For each vested RSU, the reporting person will be entitled to receive one share of common stock. |